These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2185487)

  • 21. International Symposium on the Mechanism of Action of Cyclosporine. Basel, Switzerland, June 16-18, 1987. Proceedings.
    Transplantation; 1988 Aug; 46(2 Suppl):1S-142S. PubMed ID: 3406979
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of cyclosporine and some derivatives on chronic rejection.
    Lu X; Dawson J; Borel JF
    Transplant Proc; 1996 Dec; 28(6):3152-3. PubMed ID: 8962221
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of cyclosporine on anesthetic action.
    Cirella VN; Pantuck CB; Lee YJ; Pantuck EJ
    Anesth Analg; 1987 Aug; 66(8):703-6. PubMed ID: 3605689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporine and analogues: structural requirements for immunosuppressive activity.
    Wenger R
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):213-8. PubMed ID: 3787710
    [No Abstract]   [Full Text] [Related]  

  • 25. Cyclosporine: mechanism of action, measurement and clinical use.
    Keown PA; Stiller CR; Carruthers G; Freeman D; Stawecki M
    Br J Clin Pract; 1986 Apr; 40(4):149-56. PubMed ID: 3488070
    [No Abstract]   [Full Text] [Related]  

  • 26. Cyclosporine A in contrast to a cyclosporine metabolite (OL-17) specifically inhibits growth of renal cells in culture.
    Cole E; Skorecki K; Cheung F; Wong PY; Fung LS; Levy GA
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):732-7. PubMed ID: 3388511
    [No Abstract]   [Full Text] [Related]  

  • 27. Cyclosporine and murine responses to alloantigens: effects of cyclosporine and donor-specific transfusions on delayed hypersensitivity reactions and murine skin allografts.
    Mottram PL; Mirisklavos A; Clunie GJ
    Transplant Proc; 1985 Apr; 17(2):1646-9. PubMed ID: 3885498
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunosuppression: building on Sandimmune (cyclosporine).
    Borel JF
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):149-53. PubMed ID: 2964748
    [No Abstract]   [Full Text] [Related]  

  • 29. Pretreatment with phenobarbitone modifies suppressant effect of cyclosporine on wound healing.
    Sequeira RP; Holla RK; Kulkarni DR
    Indian J Exp Biol; 1989 Jan; 27(1):41-3. PubMed ID: 2606521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of parathyroid hormone and interleukin 1-stimulated bone resorption by cyclosporine A but not by cyclosporine H or F.
    Stewart PJ; Stern PH
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):989-92. PubMed ID: 3260420
    [No Abstract]   [Full Text] [Related]  

  • 31. Proceedings of the Second International Congress on Cyclosporine. November 4-7, 1987, Washington, DC. I. Nature of the agent and its immunologic actions.
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):1-734. PubMed ID: 3363636
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of cyclosporine on the isolated perfused rat kidney.
    Luke DR; Kasiske BL; Matzke GR; Awni WM; Keane WF
    Transplantation; 1987 Jun; 43(6):795-9. PubMed ID: 3590298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical cyclosporine and contact dermatitis in guinea pig and man.
    Reitamo S; Käyhkö K; Lauerma AI; Mustakallio KK
    Arch Dermatol; 1989 Apr; 125(4):568. PubMed ID: 2930220
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunologic properties of a sulphate conjugate of cyclosporine A.
    Johansson A; Henricsson S; Möller E
    Transplant Proc; 1990 Feb; 22(1):213. PubMed ID: 2309318
    [No Abstract]   [Full Text] [Related]  

  • 35. Renal handling and nephrotoxic effects of 3H-cyclosporine in the hen.
    Milton A; Odlind B; Dencker L
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):79-85. PubMed ID: 3787719
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of the pharmacological profiles of cyclosporine, (Nva2)-cyclosporine and (Val2)dihydro-cyclosporine.
    Hiestand PC; Gunn HC; Gale JM; Ryffel B; Borel JF
    Immunology; 1985 Jun; 55(2):249-55. PubMed ID: 3891595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potentiation of cyclosporine by verapamil in vitro.
    McMillen MA; Tesi RJ; Baumgarten WB; Jaffe BM; Wait RB
    Transplantation; 1985 Oct; 40(4):444-6. PubMed ID: 4049498
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of cyclosporin A and G with and without azathioprine regarding immunosuppressive efficacy, toxicity, and pharmacokinetics in Lewis rats.
    Hagberg RC; Hoyt EG; Billingham ME; Sibley RK; Starnes VA; Baldwin JC
    J Heart Transplant; 1988; 7(5):359-69. PubMed ID: 3058906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporin A and G inhibition of cytokine production.
    Szturm K; Jeffery JR; Rush DN; McKenna RM
    Transplant Proc; 1989 Feb; 21(1 Pt 1):857. PubMed ID: 2705251
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of cyclosporine on liver regeneration.
    Grant D; Black R; Zhong R; Wall W; Stiller C; Duff J
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):877-9. PubMed ID: 3388522
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.